Fragile X syndrome
-
Plymouth Meeting’s Harmony Biosciences Drug Trial Misses Mark, Shares Drop
Plymouth Meeting’s Harmony Biosciences saw its stock tumble more than 16% this week, writes John George for the Philadelphia Business…
-
Plymouth Meeting’s Harmony Biosciences Holdings Acquires Zynerba Pharmaceuticals
Harmony Biosciences Holdings in Plymouth Meeting has agreed to buy Zynerba Pharmaceuticals for up to $200 million, writes John George…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
